DAL
42
2
DLTR
48
-2
SCHW
45
3
ECL
59
-3
VMC
68
5
WAT
49
-6
LLY
50
-3
F
35
-12
JNPR
60
6
NWS
73
-2
HRL
44
5
SYY
54
2
ITW
61
5
PFE
52
3
HSY
58
11
INTU
65
2
APA
48
2
IFF
54
-2
SYK
48
-11
SLB
60
12
DAL
42
2
DLTR
48
-2
SCHW
45
3
ECL
59
-3
VMC
68
5
WAT
49
-6
LLY
50
-3
F
35
-12
JNPR
60
6
NWS
73
-2
HRL
44
5
SYY
54
2
ITW
61
5
PFE
52
3
HSY
58
11
INTU
65
2
APA
48
2
IFF
54
-2
SYK
48
-11
SLB
60
12
Financhill
Back

Beam Therapeutics Stock Predictions

Free presentation on how to trade options for overnight gains

Get the free overnight options training here.
Buy
71

BEAM
Beam Therapeutics

Last Price:
33.16
Seasonality Move:
-10%

7 Day Trial

ALL ACCESS PASS

$ 7

Wall Street's Worst Nightmare: Small Town Trader's AI Edge

See the AI advantage for everyday Americans.

Beam Therapeutics Stock Forecast

  • Over the next 52 weeks, Beam Therapeutics has on average historically risen by 53.4% based on the past 4 years of stock performance.
  • Beam Therapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
  • Is Beam Therapeutics Stock Undervalued?
    The current Beam Therapeutics [BEAM] share price is $32.14. The Score for BEAM is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • BEAM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Beam Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Beam Therapeutics has on average historically risen by 53.4% based on the past 4 years of stock performance.

Beam Therapeutics Stock Rating

Buy
71
Beam Therapeutics (BEAM) is a Buy

Is Beam Therapeutics overpriced?

  • Beam Therapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%

Beam Therapeutics Stock Price History

Is BEAM stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BEAM is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
beamtx.com

52-Week Data

52-Week High:
49.50
52-Week Low:
16.95

Prediction Charts

Market Cap:
2.65B
Price in USD:
32.14
Volume:
2.34M
Beta:
1.80

Technical Analysis

SMA50:
24.85
SMA100:
26.90
SMA200:
26.85
52-Wk Change:
-0.99%

Stock Predictions

  • Is Beam Therapeutics stock public?
    Yes, Beam Therapeutics is a publicly traded company.
  • What is the Beam Therapeutics stock quote today?
    The Beam Therapeutics stock price is 32.14 USD today.
  • How to buy Beam Therapeutics stock online?
    You can buy Beam Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jul-8 23.43 23.85 24.21 23.18
Jul-9 23.71 23.84 24.05 23.36
Jul-10 23.92 23.96 24.41 23.62
Jul-11 24.80 25.88 26.80 24.71
Jul-12 26.31 26.88 27.62 25.81
Jul-15 25.59 25.60 25.66 24.30
Jul-16 25.85 27.29 27.45 25.83
Jul-17 26.76 26.93 27.52 26.40
Jul-18 26.84 25.46 27.47 25.41
Jul-19 25.50 25.94 25.98 24.69
Jul-22 26.29 27.05 27.25 25.56
Jul-23 27.80 30.32 30.83 27.30
Jul-24 29.89 29.81 30.97 29.21
Jul-25 29.88 32.14 33.43 29.88

Beam Therapeutics Earnings

Beam Therapeutics Earnings Report: Per Share Beam Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Beam Therapeutics Forecast Revenue Growth

Beam Therapeutics Stock Analysis: Historical quarterly revenues per share for Beam Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.48 per share, and an increase next year of $0.06 per share.

* Beam Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.